Searchable abstracts of presentations at key conferences in endocrinology

ea0059cmw5.5 | Workshop 5: How do I. . . (2) | SFEBES2018

How do I know which non-diabetic patients could benefit from a GLP-1 analogue

Gowan Barbara Mc

The physiological effects of glucagon-like peptide (GLP-1) are of great interest because of their potential clinical relevance. GLP-1 is secreted by the L-cells of the distal ileum and colon in response to nutrient ingestion. It acts as an incretin hormone and augments glucose-stimulated insulin secretion in the pancreas. The use of GLP-1 agonists for the treatment of Type 2 Diabetes (T2DM) is well established. However, GLP-1 has several other physiological functions. It acts ...

ea0059p108 | Diabetes & cardiovascular | SFEBES2018

Nrf2 mediated protection against hypoglycaemia induced cognitive deficits in type 1 diabetes

Mc Neilly Alison , Gallagher Jennifer , McCrimmon Rory

Background: Hypoglycaemia in Type 1 diabetes (T1D) and type 2 diabetes is associated with long-term cognitive dysfunction. We have previously demonstrated that recurrent hypoglycaemia (RH) in a rodent model of T1D induces oxidative stress and inflammation in the hippocampus, associated with impaired cognitive function. This study sought to investigate whether pre-treatment with a potent inducer of the antioxidant response would ameliorate these cognitive deficits.<p class=...

ea0059ep41 | Clinical practice, governance &amp; case reports | SFEBES2018

Macrohormones: bigger isn’t always better

Kanonidou Christina , Mc Neilly Jane , Srivastava Rajeev

Introduction: Macrohormones are complexes of monomeric hormone molecules with IgG leading to formation of macrocomplexes. They are usually immunoreactive, but biologically inactive. The higher molecular weight results in reduced renal clearance and therefore accumulation in the blood. We present two cases of unusual macrohormones.Case 1: A 55-year-old male had his thyroid function checked as part of investigation for chest pain, and was started on thyrox...

ea0014p186 | (1) | ECE2007

X-linked neuronal T3 transport defect: Allan Herndon Dudley syndrome

Dugal Tabinda , Albanese Assunta , Mc Entagart Muriel

Thyroid hormone is absolutely necessary for early brain development.Incidence of thyroid disorders in infancy is 1:4,000.Thyroid hormones can be deficient through hormone synthesis and action or very rarely through defective transport. Some new and exciting transporters for tri-iodothyronine (T3) have recently come to light.MCT 8 gene encodes the protein that transports T3 into neurons. Its mutation result in inability of T3 to enter a developi...

ea0008p30 | Diabetes, metabolism and cardiovascular | SFE2004

EPIDEMIOLOGICAL STUDY ON GLYCEMIA CONTROL IN PATIENTS WITH DM1 AND DM2, Epicon study- baseline visit analysis

Sanabria MC , Rodriguez J , Badia X , Novials A

INTRODUCTION:Diabetes Mellitus is one of the most important problems which has greater health care impact in Spain. It is concluded from the DCCT study on DM1 and UKPDS in DM2 that control of HbA1c levels is essential to reduce chronic complications. Guidelines suggest maintaining HbA1c levels below 7%.PATIENTS AND METHODS:Design: Epidemiological, longitudinal, prospective and multicenter study in Spain, with two cohorts, DM1 (n=40...

ea0008p74 | Reproduction | SFE2004

Effect of gonadotrophin and insulin on the balance of sterol regulatory element-binding protein(SREBP) isoforms in human granulosa cells

Richardson MC , Cameron IT , Simonis CD , Das MC , Hodge TE , Zhang J , Byrne CD

Clinical insulin resistance, concomitant with higher circulating insulin, is implicated in the pathogenesis of polycystic ovary syndrome (PCOS) in which there is abnormal lipid metabolism with changes in ovarian hormone production. SREBPs are key transcriptional regulators of lipid biosynthesis and therefore may be involved in changes occurring in PCOS. We have examined whether insulin and gonadotrophin regulate SREBPs.Local ethical approval was granted ...

ea0051p023 | Miscellaneous/other | BSPED2017

Exploring the growth and nutritional status in children with Prader-Willi syndrome

Martin Ruth , Meade Christina , Mc Crann Ann , Roche Edna

Background: Prader-Willi syndrome (PWS) is a rare complex genetic disease. Nutritional needs vary depending on life stage, ranging from growth faltering in infancy to obesity from late childhood. Dietetic care is a main pillar of the multidisciplinary team (MDT) approach for PWS management. National Children Hospital (NCH) is the main national centre for PWS in Ireland, with 47 children attending. We sought to explore growth and nutritional status in children with PWS.<p c...

ea0081ep421 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The effects of Semaglutide on glycaemic control and weight, in type two diabetic patients, in our diabetic day center

Al-Shaibany Azhar , Mc Cabe Olivia , Shabaht Shah

Introduction: Type two diabetes is characterized by a chronic metabolic state (obesity, high blood pressure, and dyslipidemia) and insulin resistance. There is insufficient pancreatic insulin production and ineffective use of the produced insulin resulting in abnormally high blood glucose levels (hyperglycaemia). Metabolic syndrome and diabetes are associated with increased cardiovascular risk, reduced life expectancy and a reduction in quality of life. Glucagon-like peptide 1...

ea0021p167 | Diabetes and metabolism | SFEBES2009

Liraglutide prevents endothelial damage triggered by glucose oscillations

Schisano Bruno , Radford Claire , Harte Allison , Mc Ternan Phillip , Ceriello A

Background: Since it has been shown that markers of oxidative stress persist in endothelial cells that have been exposed for a prolonged time to chronic constant high glucose levels, long after glucose normalization, a phenomenon defined as ‘metabolic memory’, evaluation of chronic exposure to oscillating high glucose, its impact on the induction of cellular stress markers and the onset of a ‘metabolic memory’ might be of pivotal interest. In doing so we al...